31 January 2024
CVS Group
plc
("CVS" or
the "Company")
Exercise of Options and Total
Voting Rights
CVS, one of the UK's leading
providers of integrated veterinary services, confirms that certain
employees have exercised options during January under the CVS Group
2020 SAYE Plan (2020/2024) totalling 211,401 ordinary shares of 0.2
pence each ("Ordinary Shares"). One employee also exercised options
under the CVS Group Long Term Incentive Plan 2020 ("LTIP 14") over
6,733 new Ordinary Shares.
The issuance of shares in connection
with the SAYE Exercise was partially satisfied by 47,300 Ordinary
Shares held by the CVS Group Employee Benefit Trust (the
"EBT"). Additionally, the issuance of shares in connection
with the LTIP 14 Exercise was fully satisfied by 6,733 Ordinary
Shares held by the EBT. Following the SAYE and LTIP 14 Exercise, a
total of 645 Ordinary Shares are held by the EBT, representing
approximately 0.001% of the Company's total voting
rights.
The sum of 164,101 new Ordinary
Shares were issued to partially satisfy the balance of Ordinary
Shares arising from the SAYE Exercise. Admission of the
164,101 new Ordinary Shares has been satisfied by the Company's
block listing admitted to the London Stock Exchange on 30 December
2021.
Following the issue of these new
Ordinary Shares, which rank pari passu in all respects with the
Company's existing Ordinary Shares, the Company has a total issued
share capital of 71,701,763 Ordinary Shares, each carrying one
voting right. The Company holds no Ordinary Shares in treasury and
the total number of voting rights is therefore
71,701,763.
This figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest, or a
change to their interest, in the Company under the FCA's Disclosure
Guidance and Transparency Rules.
Contacts:
CVS Group
plc
via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP
(Nominated Adviser &
Broker)
+44 (0)20 7418 8900
Adrian Trimmings / Michael Burke / Andrew Clark
/ Lalit Bose
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo
Bonser
Camarco
(Financial
PR)
Geoffrey
Pelham-Lane
+44 (0)7733 124
226
Ginny
Pulbrook
+44 (0)7961 315
138
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of
veterinary services in the UK, Australia, the Netherlands and the
Republic of Ireland. CVS is focused on providing high quality
clinical services to its clients and their animals, with
outstanding and dedicated clinical teams and support colleagues at
the core of its strategy.
The Group has c.500 veterinary practices across
its four markets, including nine specialist referral hospitals and
39 dedicated out-of-hours sites. Alongside the core Veterinary
Practices division, CVS operates Laboratories (providing diagnostic
services to CVS and third-parties), Crematoria (providing pet
cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business
("Animed Direct").
The Group employs c.9,000 personnel, including
c.2,400 veterinary surgeons and c.3,300 nurses.